
    
      Normal healthy subjects will be recruited and consented for the study. Following completion
      of the study, the bio-marker samples will be sent to Dr. Anthony Suffredini a collaborator
      and Deputy Chief & Senior Investigator Department of Critical Care Medicine at the National
      Institutes of Health (NIH). All samples will be de-identified and analyzed at the NIH; the
      results of which will be reviewed by both Drs. Suffredini and Noveck. Statistical analysis
      will be performed at the NIH by the Department of Statistics from which manuscripts will be
      written for publication.
    
  